Publications by authors named "N Shariati"

Introduction: Prasinezumab was shown to potentially delay motor progression in individuals with early-stage Parkinson's disease (PD) who were either treatment-naïve or on monoamine oxidase type B inhibitor (MAO-Bi) therapy in the PASADENA study. We report the rationale, design, and baseline patient characteristics of the PADOVA study, designed to evaluate prasinezumab in an early-stage PD population receiving standard-of-care (SOC) symptomatic medications.

Methods: PADOVA (NCT04777331) is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, in which individuals with early-stage PD on SOC stable symptomatic monotherapy (levodopa or MAO-Bi) receive intravenous prasinezumab 1500 mg every 4 weeks.

View Article and Find Full Text PDF

Light propagation facilitates digital information encryption by utilizing Epsilon Negative (ENG) metamaterials as a medium. Achieving the desired encryption hinges on synchronizing two pivotal features: the phase difference and the epsilon shifting of the metamaterials. The proposed metamaterial is intricately designed to represent digital bit 1 (states 0 and 1), contingent upon the arrangement of material multilayers within the metamaterial device.

View Article and Find Full Text PDF

Continuous and accurate sensing of water content in soil is an essential and useful measure in the agriculture industry. Traditional sensors developed to perform this task suffer from limited lifetime and also need to be calibrated regularly. Further, maintenance, support, and deployment of these sensors in remote environments provide additional challenges to the use of conventional soil moisture sensors.

View Article and Find Full Text PDF

Introduction: Chronic pain is a major public health concern, as is the associated use of opioid medications, highlighting the importance of alternative treatments, such as spinal cord stimulation (SCS). Here, we present the final 24-month results of the Avalon study, which investigated the use of the first closed-loop SCS system in patients with chronic pain. The system measures the evoked compound action potentials (ECAPs) elicited by each stimulus pulse and drives a feedback loop to maintain the ECAP amplitude near constant.

View Article and Find Full Text PDF